研究单位：[1]Shenyang Dongxing Pharmaceutical Technology Co.,Ltd.[2]Xuanwu Hospital Capital Medical University Beijing,Beijing,China,100053
研究目的：
A Randomized, Open-label, Single Dose, Two Formulation, Two Period, Double Cross Over Bioavailability Comparison Study of two types of Nimodipine Injections in Healthy Volunteers.
